To Determine Bioequivalence Under Fasting Conditions Completed Phase 1 Trials for Clonazepam (DB01068)

IndicationStatusPhase
DBCOND0039998 (To Determine Bioequivalence Under Fasting Conditions)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00652912Bioavailability Study of Clonazepam ODT Under Fasting Conditions
NCT00652639Bioavailability Study of Clonazepam Tablets Under Fasting Conditions